Satoshi Ōmura
| Satoshi Ōmura | |
|---|---|
Satoshi Ōmura, Nobel Laureate in medicine in Stockholm December 2015
|
|
| Native name | 大村 智 |
| Born |
12 July 1935 Nirasaki, Yamanashi, Japan |
| Nationality | Japanese |
| Fields | Biochemistry |
| Institutions |
Kitasato University Wesleyan University |
| Alma mater |
University of Yamanashi Tokyo University of Science (M.S., Sc. D.) University of Tokyo (Ph.D.) |
| Academic advisors |
Koji Nakanishi Max Tishler |
| Known for | Avermectin and Ivermectin |
| Notable awards |
Japan Academy Prize (1990) Koch Gold Medal (1997) Gairdner Global Health Award (2014) Nobel Prize in Physiology or Medicine (2015) |
Satoshi Ōmura [satoɕi oːmu͍ɽa] (大村 智 Ōmura Satoshi?, born 12 July 1935) is a Japanese biochemist. He is known for the discovery and development of various pharmaceuticals originally occurring in microorganisms. In 2015, he was awarded the Nobel Prize in Physiology or Medicine jointly with William C. Campbell and Tu Youyou.
Satoshi Ōmura was born in Nirasaki, Yamanashi, Japan, in 1935, the second son of Ōmura family. After graduating from the University of Yamanashi in 1958, he was appointed to science teacher at . In 1960, he became an auditor of Koji Nakanishi at Tokyo University of Education, one year later, he enrolled in the Tokyo University of Science (TUS) and studied sciences. Ōmura received his M.S. degree from TUS and his Ph.D. in Pharmaceutical Sciences from the University of Tokyo and a Ph.D. in Chemistry at the TUS.
Satoshi Ōmura is professor emeritus at Kitasato University and Max Tishler Professor of Chemistry at Wesleyan University. He is known for the discovery and development of various pharmaceuticals originally occurring in microorganisms. He was awarded the 2015 Nobel Prize in Physiology or Medicine jointly with William C. Campbell and Tu Youyou for discoveries concerning a novel therapy against infections caused by roundworm parasites. More precisely, his research group isolated a strain of Streptomyces avermitilis that produce the anti-parasitical compound avermectin. Campbell later acquired these bacteria and developed the derived drug ivermectin that is today used against river blindness, lymphatic filariasis and other parasitic infections.
...
Wikipedia